| Year |
Citation |
Score |
| 2022 |
Biggane JP, Xu K, Goldenstein BL, Davis KL, Luger EJ, Davis BA, Jurgens CWD, Perez DM, Porter JE, Doze VA. Pharmacological characterization of the α-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency. Journal of Receptor and Signal Transduction Research. 1-8. PMID 35984443 DOI: 10.1080/10799893.2022.2110896 |
0.788 |
|
| 2014 |
Collette KM, Zhou XD, Amoth HM, Lyons MJ, Papay RS, Sens DA, Perez DM, Doze VA. Long-term α1B-adrenergic receptor activation shortens lifespan, while α1A-adrenergic receptor stimulation prolongs lifespan in association with decreased cancer incidence. Age (Dordrecht, Netherlands). 36: 9675. PMID 24994537 DOI: 10.1007/S11357-014-9675-7 |
0.764 |
|
| 2014 |
Paukert M, Agarwal A, Cha J, Doze VA, Kang JU, Bergles DE. Norepinephrine controls astroglial responsiveness to local circuit activity. Neuron. 82: 1263-70. PMID 24945771 DOI: 10.1016/j.neuron.2014.04.038 |
0.633 |
|
| 2011 |
Doze VA, Papay RS, Goldenstein BL, Gupta MK, Collette KM, Nelson BW, Lyons MJ, Davis BA, Luger EJ, Wood SG, Haselton JR, Simpson PC, Perez DM. Long-term α1A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood, and longevity. Molecular Pharmacology. 80: 747-58. PMID 21791575 DOI: 10.1124/Mol.111.073734 |
0.727 |
|
| 2011 |
Perez DM, Doze VA. Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes. Journal of Receptor and Signal Transduction Research. 31: 98-110. PMID 21338248 DOI: 10.3109/10799893.2010.550008 |
0.335 |
|
| 2009 |
Doze VA, Handel EM, Jensen KA, Darsie B, Luger EJ, Haselton JR, Talbot JN, Rorabaugh BR. alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Research. 1285: 148-57. PMID 19540213 DOI: 10.1016/J.Brainres.2009.06.035 |
0.426 |
|
| 2009 |
Gupta MK, Papay RS, Jurgens CW, Gaivin RJ, Shi T, Doze VA, Perez DM. alpha1-Adrenergic receptors regulate neurogenesis and gliogenesis. Molecular Pharmacology. 76: 314-26. PMID 19487244 DOI: 10.1124/mol.109.057307 |
0.779 |
|
| 2009 |
Xiao Z, Deng PY, Rojanathammanee L, Yang C, Grisanti L, Permpoonputtana K, Weinshenker D, Doze VA, Porter JE, Lei S. Noradrenergic depression of neuronal excitability in the entorhinal cortex via activation of TREK-2 K+ channels. The Journal of Biological Chemistry. 284: 10980-91. PMID 19244246 DOI: 10.1074/Jbc.M806760200 |
0.345 |
|
| 2009 |
Goldenstein BL, Nelson BW, Xu K, Luger EJ, Pribula JA, Wald JM, O'Shea LA, Weinshenker D, Charbeneau RA, Huang X, Neubig RR, Doze VA. Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activity. Molecular Pharmacology. 75: 1222-30. PMID 19225179 DOI: 10.1124/Mol.108.054296 |
0.804 |
|
| 2009 |
Hillman KL, Lei S, Doze VA, Porter JE. Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus. Epilepsy Research. 84: 97-109. PMID 19201164 DOI: 10.1016/J.Eplepsyres.2008.12.007 |
0.557 |
|
| 2008 |
Luger E, Davis K, Goldenstein B, Nelson B, Xu K, Pribula J, Wald J, Weinshenker D, Doze V. Alpha2A adrenergic receptor‐mediated inhibition of mouse hippocampal CA3 network activity The Faseb Journal. 22: 98-98. DOI: 10.1096/Fasebj.22.2_Supplement.98 |
0.783 |
|
| 2007 |
Jurgens CW, Hammad HM, Lichter JA, Boese SJ, Nelson BW, Goldenstein BL, Davis KL, Xu K, Hillman KL, Porter JE, Doze VA. Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region. Molecular Pharmacology. 71: 1572-81. PMID 17341653 DOI: 10.1124/Mol.106.031773 |
0.756 |
|
| 2007 |
Hillman KL, Doze VA, Porter JE. Alpha1A-adrenergic receptors are functionally expressed by a subpopulation of cornu ammonis 1 interneurons in rat hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 321: 1062-8. PMID 17337632 DOI: 10.1124/Jpet.106.119297 |
0.464 |
|
| 2006 |
Papay R, Gaivin R, Jha A, McCune DF, McGrath JC, Rodrigo MC, Simpson PC, Doze VA, Perez DM. Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. The Journal of Comparative Neurology. 497: 209-22. PMID 16705673 DOI: 10.1002/Cne.20992 |
0.46 |
|
| 2005 |
Jurgens CW, Boese SJ, King JD, Pyle SJ, Porter JE, Doze VA. Adrenergic receptor modulation of hippocampal CA3 network activity. Epilepsy Research. 66: 117-28. PMID 16140503 DOI: 10.1016/j.eplepsyres.2005.07.007 |
0.806 |
|
| 2005 |
Hillman KL, Knudson CA, Carr PA, Doze VA, Porter JE. Adrenergic receptor characterization of CA1 hippocampal neurons using real time single cell RT-PCR. Brain Research. Molecular Brain Research. 139: 267-76. PMID 16005103 DOI: 10.1016/J.Molbrainres.2005.05.033 |
0.456 |
|
| 2005 |
Hillman KL, Doze VA, Porter JE. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 314: 561-7. PMID 15908513 DOI: 10.1124/Jpet.105.084947 |
0.434 |
|
| 2005 |
Jurgens CW, Rau KE, Knudson CA, King JD, Carr PA, Porter JE, Doze VA. Beta1 adrenergic receptor-mediated enhancement of hippocampal CA3 network activity. The Journal of Pharmacology and Experimental Therapeutics. 314: 552-60. PMID 15908512 DOI: 10.1124/jpet.105.085332 |
0.802 |
|
| 2002 |
Hintz KK, Norby FL, Duan J, Cinnamon MA, Doze VA, Ren J. Comparison of cardiac excitation-contraction coupling in isolated ventricular myocytes between rat and mouse. Comparative Biochemistry and Physiology. Part a, Molecular & Integrative Physiology. 133: 191-8. PMID 12160885 DOI: 10.1016/S1095-6433(02)00177-0 |
0.396 |
|
| 1998 |
Doze VA, MacIver MB. HALOTHANE ACTS ON RYANODINE SENSITIVE CALCIUM RELEASE CHANNELS TO ENHANCE PRESYNAPTIC GABA RELEASE Anesthesiology. 89: 722A. DOI: 10.1097/00000542-199809130-00028 |
0.534 |
|
| 1997 |
Doze VA, Monroe FA, MacIver MB. A626 HALOTHANE ENHANCES PRESYNAPTIC GABA RELEASE BY INCREASING INTERNAL CALCIUM Anesthesiology. 87: 626A. DOI: 10.1097/00000542-199709001-00626 |
0.566 |
|
| 1996 |
Bergles DE, Doze VA, Madison DV, Smith SJ. Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 572-85. PMID 8551341 DOI: 10.1523/Jneurosci.16-02-00572.1996 |
0.777 |
|
| 1995 |
Doze VA, Cohen GA, Madison DV. Calcium channel involvement in GABAB receptor-mediated inhibition of GABA release in area CA1 of the rat hippocampus. Journal of Neurophysiology. 74: 43-53. PMID 7472344 DOI: 10.1152/Jn.1995.74.1.43 |
0.735 |
|
| 1992 |
Cohen GA, Doze VA, Madison DV. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron. 9: 325-35. PMID 1497896 DOI: 10.1016/0896-6273(92)90171-9 |
0.719 |
|
| 1992 |
Parfitt KD, Doze VA, Madison DV, Browning MD. Isoproterenol increases the phosphorylation of the synapsins and increases synaptic transmission in dentate gyrus, but not in area CA1, of the hippocampus. Hippocampus. 2: 59-64. PMID 1339193 DOI: 10.1002/hipo.450020108 |
0.795 |
|
| 1991 |
Meffert MK, Parfitt KD, Doze VA, Cohen GA, Madison DV. Protein kinases and long-term potentiation. Annals of the New York Academy of Sciences. 627: 2-9. PMID 1679309 DOI: 10.1111/J.1749-6632.1991.Tb25909.X |
0.727 |
|
| 1991 |
Savola MK, MacIver MB, Doze VA, Kendig JJ, Maze M. The alpha 2-adrenoceptor agonist dexmedetomidine increases the apparent potency of the volatile anesthetic isoflurane in rats in vivo and in hippocampal slice in vitro. Brain Research. 548: 23-8. PMID 1678296 DOI: 10.1016/0006-8993(91)91101-6 |
0.773 |
|
| 1991 |
Doze VA, Cohen GA, Madison DV. Synaptic localization of adrenergic disinhibition in the rat hippocampus. Neuron. 6: 889-900. PMID 1675862 DOI: 10.1016/0896-6273(91)90229-S |
0.757 |
|
| 1990 |
Doze VA, Chen BX, Tinklenberg JA, Segal IS, Maze M. Pertussis toxin and 4-aminopyridine differentially affect the hypnotic-anesthetic action of dexmedetomidine and pentobarbital. Anesthesiology. 73: 304-7. PMID 1974396 DOI: 10.1097/00000542-199008000-00019 |
0.37 |
|
| 1989 |
Doze V, Chen BX, Li Z, Maze M. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine Acta Veterinaria Scandinavica. Supplementum. 85: 61-64. PMID 2571279 |
0.321 |
|
| 1989 |
Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology. 71: 75-9. PMID 2568769 |
0.319 |
|
| 1989 |
Savola MK, MacIver MB, Doze VA, Maze M, Kendig JJ. INTERACTION OF DEXMEDETOMIDINE, AN α,-ADRENOCEPTOR AGONIST, WITH ISOFLURANE IN RAT HIPPOCAMPAL CA1 NEURONS Anesthesiology. 71: A597. DOI: 10.1097/00000542-198909001-00597 |
0.738 |
|
| 1989 |
Doze VA, MacIver MB. DEXMEDETOMIDINE- INDUCED EXCITATION OF RAT HIPPOCAMPAL CA1 NEURONS RESEMBLES THE EFFECTS OF OPIATE NARCOTICS Anesthesiology. 71: A578. DOI: 10.1097/00000542-198909001-00578 |
0.658 |
|
| 1988 |
Segal IS, Vickery RG, Walton JK, Doze VA, Maze M. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology. 69: 818-23. PMID 2848424 DOI: 10.1097/00000542-198812000-00004 |
0.401 |
|
| 1988 |
Vickery RG, Doze VA, Segal IS, Maze M. HALOTHANE HAC IS STEREOSPECIFICALLY REDUCED BY MEDETOMIDINE, AN ALPHA2 AGONIST Anesthesia & Analgesia. 67: 245. DOI: 10.1213/00000539-198802001-00245 |
0.38 |
|
| 1988 |
Segal IS, Doze VA, Sheridan BC, Vickery RG, Maze M. DOES MEDETOMIDINE DECREASE ANESTHETIC REQUIREMENTS THROUGH BOTH PRE AND POSTSYNAPTIC ALPHA2 ADRENORECEPTORS? Anesthesia & Analgesia. 67: 199. DOI: 10.1213/00000539-198802001-00199 |
0.378 |
|
| 1988 |
Doze V, Chen B, Li Z, Vickery R, Maze M. CHARACTERIZATION OF THE ALPHA2 ADRENOCEPTOR-EFFECTOR MECHANISM FOR THE HYPNOTIC ACTION OF MPV-1440 IN RATS Anesthesiology. 69: A619-A619. DOI: 10.1097/00000542-198809010-00619 |
0.365 |
|
| Show low-probability matches. |
